Mwanzo0853 • HKG
add
MicroPort Scientific Corp
Bei iliyotangulia
$ 12.46
Bei za siku
$ 12.73 - $ 14.16
Bei za mwaka
$ 5.53 - $ 16.28
Thamani ya kampuni katika soko
24.64B HKD
Wastani wa hisa zilizouzwa
16.96M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
HKG
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 273.77M | -2.00% |
Matumizi ya uendeshaji wa biashara | 153.68M | -14.80% |
Mapato halisi | -23.30M | 51.87% |
Kiwango cha faida halisi | -8.51 | 50.89% |
Mapato kwa kila hisa | — | — |
EBITDA | 26.04M | 99.76% |
Asilimia ya kodi ya mapato | -86.95% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 957.62M | -7.63% |
Jumla ya mali | 3.77B | -0.59% |
Jumla ya dhima | 2.59B | 3.36% |
Jumla ya hisa | 1.18B | — |
hisa zilizosalia | 1.85B | — |
Uwiano wa bei na thamani | 36.65 | — |
Faida inayotokana na mali | 0.04% | — |
Faida inayotokana mtaji | 0.05% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -23.30M | 51.87% |
Pesa kutokana na shughuli | -5.77M | 65.49% |
Pesa kutokana na uwekezaji | -3.17M | 96.31% |
Pesa kutokana na ufadhili | 33.95M | 201.05% |
Mabadiliko halisi ya pesa taslimu | 25.75M | 118.43% |
Mtiririko huru wa pesa | 12.88M | 421.18% |
Kuhusu
MicroPort is a multinational medical technology company with headquarters in Shanghai; Irvine, California; and Clamart, France. The company designs and produces medical devices across multiple therapeutic areas including interventional cardiology, orthopedics, cardiac rhythm management, electrophysiology, neurovascular intervention, structural heart disease, surgical robotics, and critical care.
MicroPort completed its initial public offering on the Hong Kong Stock Exchange in 2010 and has since established multiple specialized subsidiaries focused on distinct therapeutic areas, with several completing separate public listings. Recognized as one of the global Medtech Big 100 companies, MicroPort's coronary intervention products have been implanted in over 10 million patients globally since its founding, with devices distributed globally in over 90 countries across. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1998
Tovuti
Wafanyakazi
6,287
